Run your trial in Australia and skip the delays, red tape, and overhead
Get FDA-accepted data, start without an IND, and claim up to 43.5% back in R&D rebates. We’ll help you activate faster and spend less.
Why sponsors choose Australia
Australia offers a powerful combination of speed, savings, and regulatory clarity. It’s one of the most efficient regions in the world for early phase trials.
30-50% cost savings
Running a clinical trial in Australia typically costs around 30% less than in the US or Europe. When paired with the government rebate, the total cost savings can exceed 50%.


43.5% tax rebate
Companies with less than AUD20 million in annual turnover can claim a 43.5% cash rebate on eligible trial costs. This incentive gives you real money back to reinvest in your pipeline.
You can start a clinical trial in Australia without waiting for US FDA IND approval. Studies can begin earlier, often by several months, and the data can still support future IND submissions.
No IND required




How trials start in Australia
Australia offers one of the most streamlined regulatory pathways for early phase trials. Here’s what it takes to get started:
Ethics approval
Submit your protocol to a Human Research Ethics Committee. Most reviews are completed in 4 to 8 weeks. You can begin preparing sites and documents at the same time.
Notify the TGA
After HREC approval, submit a Clinical Trial Notification to the Therapeutic Goods Administration. There is no additional review, only a formal notification and fee.
Once site approvals are in place, your study can start. IND clearance is not required to begin dosing in Australia. Data from these studies can support future FDA or EMA submissions.
Begin your study








Frequently asked questions
Do I need a local sponsor or entity to run a clinical trial in Australia?
Yes, a local Australian sponsor or legal representative is required. Freelance Clinical can help you fulfill this role and navigate local governance with the right partners.
Can I start a clinical trial in Australia without FDA IND approval?
Yes. You can start a Phase I trial in Australia before IND approval. This allows you to generate early data that can later support your FDA submission.
How long does it take to start a clinical trial in Australia?
Most trials start within 8 to 12 weeks. Ethics approval typically takes 4 to 8 weeks, followed by TGA notification and site approvals which can run in parallel.
Is the 43.5% R&D tax incentive available to international companies?
Yes, if you set up an Australian entity and meet eligibility criteria, you can access the rebate. We can guide you through the setup and help assess your eligibility.
Are clinical trial costs lower in Australia compared to the US?
Yes. Costs are typically 30 percent lower. With the R&D rebate, total savings can exceed 50 percent. Flexible models like pay-as-you-go help reduce overhead further.
Will data from Australian trials be accepted by the FDA and EMA?
Yes. Data from Australian trials is accepted by both agencies. Many sponsors begin Phase I in Australia before IND approval and use that data to support global submissions.
We’re here to help
Have questions or need more information? Reach out, and we’ll get back to you within one (1) business day.
info@freelanceclinical.com
Address
Suite 2 Level 1, 9-11 Grosvenor Street
Neutral Bay, NSW 2089 Australia
Follow us
Disclaimer: Freelance Clinical provides freelancer and vendor sourcing services for clinical research support. We do not claim to list or compare all available providers in the market. All information and recommendations are general in nature and do not constitute endorsements or guarantees. Clients are responsible for conducting their own due diligence before engaging third parties. Freelance Clinical is not liable for any outcomes resulting from such engagements. This website is governed by the laws of New South Wales, Australia.
ABN: 12 671 763 643 · © 2025 Freelance Clinical Pty Ltd. All rights reserved.